Open Access
Table 2
Treatment received by real-world patients prior to treatment with the TheraBionic device. The Table reports the number of patients who received systemic and locoregional treatments prior to treatment with the TheraBionic device.
| Prior treatments | Total |
|---|---|
| Sorafenib | 13 |
| Chemoembolization | 9 |
| Hepatectomy | 2 |
| Nivolumab | 2 |
| Radiofrequency ablation | 2 |
| Sunitinib | 1 |
| SIR-spheres | 1 |
| Lenvatinib | 1 |
| Stereotactic Body Radiation Therapy | 1 |
| Regorafenib | 1 |
| Atezolizumab plus Bevacizumab | 1 |
| Ytrium-90 radioembolization | 1 |
| Cryoablation | 1 |
| Pancreatectomy | 1 |
| Splenectomy | 1 |
| No prior treatment | 1 |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.